Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) ...
SPOP mutations in veterans with metastatic castration-resistant prostate cancer (mCRPC) and the association with race and response to an androgen receptor pathway inhibitor (ARPI). This is an ASCO ...
MedPage Today on MSN
Good Cancer Control, Survival With SBRT for Limited Metastatic/Progressive Disease
Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers.
Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...
(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress was host to a radioligand therapeutics ...
Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...
Prostate cancer is an issue many men, including former President Joe Biden, face. If a person has an “aggressive” prostate cancer with a Gleason score of 9, what does that mean? What’s the outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback